According to the agency, using these devices “may cause serious injuries or death.”

“It can be a challenging discussion to have with patients because there is evidence that cannabis has some therapeutic properties," one researcher said. "However, as suggested by this study, cannabis use also has significant cardiovascular risks.”  

The procedure, performed on Feb. 14, was part of an early feasibility trial developed with help from the FDA.

According to Philips, this latest update makes the Azurion image-guided therapy platform more efficient than ever.

The Ornish diet, a plant-based option developed to help prevent heart disease, also made the final ranking. 

Cerebral protection devices, designed to limit the risk of stroke during transcatheter aortic valve replacement, may be especially helpful when patients undergo valve-in-valve TAVR.

LumiGuide uses fiber optic realShape (FORS) technology, where light is reflected along an optical fiber inside a guidewire to generate 3D, high-resolution, color images of devices inside a patient’s body

However, that one finding does not tell the whole story. Researchers also found that DOACs may increase a TAVR patient's risk of a disabling stroke.